News & Events from TheraNetrix, Inc.

Stay up to date with the latest developments, research initiatives, and public appearances from TheraNetrix, Inc. As pioneers in digital health innovation, we regularly engage in thought leadership, strategic partnerships, and scientific events to advance the future of pain care.

News

Catch up on our latest announcements, press releases, and product updates as we continue to shape the evolution of clinical decision support in pain management.

Coming Soon: Updates on clinical collaborations, new platform features, and scientific publications.

Published Articles of Interest
Jmir dt article
Ross’s top doctor award

Events

A large group of people sitting in chairs in a room

TheraNetrix is proud to participate in key industry conferences, panels, and digital health symposiums. Check back regularly for information on where our experts will be speaking or exhibiting next.

Stay tuned for our conference lineup and live webinars.

David Guydan and Dr. Edgar Ross (TheraNetrix Chairman and Chief Medical Officer) attended the Second Annual Centri Capital Conference 2026, held April 14th at NASDAQ in New York City. Over 500 registered attendees were in attendance, including medtech, healthcare, and pharma industry leaders and a range of companies, private equity, venture capital, investment banks, and angel investors. TheraNetrix was invited to deliver a live presentation to investors, as well as to participate in one-on-one matchups. The day featured informative industry panels, fireside chats, and timely discussions on AI, energy markets, IPO markets, and the regulatory landscape. Keep posted. TheraNetrix is
already planning to attend Centri Capital Conference 2027! Look for details/dates here.

Stay tuned…live webinars.
David Guydan, TheraNetrix President & CEO, presenting to investors at the Centri Capital Conference.

David Guydan and Robert Carr attended the Wilson Sonsini Biotech Summit 2025, held October 22-23 at The Newbury in Boston. Over 400 registered attendees filled the venue, including industry leaders, established and start-up companies, investors, esteemed researchers, and policymakers. The summit featured a rich line-up of expert panel discussions on topics such as financing ventures, strategic partnerships, regulatory matters, and innovations in drug development. The ability to meet one-on-one with investors and the networking opportunities were highlights of the Summit. Thanks to Wilson Sonsini (TheraNetrix law firm) for hosting this important event.

Want to collaborate or invite us to your event?

Contact Our Team